ClinicalTrials.govpublic full text
Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
head and neck squamous cell carcinoma, hpv-negative squamous cell carcinoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 387154
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.